🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validity of the Turkish Translation of the Modified JOA

Recruitingn/aAges 18 Years - anyAllIzmir Democracy University
NCT07448883 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal cord dysfunction in adults and may lead to progressive motor, sensory, and autonomic impairment. Accurate and standardized assessment of neurological function is essential for clinical decision-making, prognostic evaluation, and comparison of treatment outcomes. The Modified Japanese Orthopaedic Association (mJOA) score is one of the most widely used clinician-based outcome measures for evaluating neurological status in patients with DCM. Although the mJOA has been translated and validated in several languages, no validated Turkish version currently exists. This prospective, cross-sectional validation study aims to culturally adapt the mJOA score into Turkish and evaluate its validity, reliability, and clinical correlation in Turkish-speaking patients diagnosed with DCM. Adult patients (≥18 years) wi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years and older * Patients diagnosed with degenerative cervical myelopathy using clinical or magnetic resonance imaging * Able to provide written informed consent to participate in the study * Cognitive competence to understand Turkish forms and scales Exclusion Criteria: * Spinal cord injury due to trauma, tumor, infection, inflammatory diseases, etc., pathologies * Previous cervical surgery * Severe cognitive impairment or communication problems that would prevent participation in the study * Subjects who were informed about the study but refused to participate
💊

What it tests

  • Not listed
📍

Where

1 site
Izmir Democracy University
Buca, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy